A Review of Triple Negtive Marker of IHC in Medullary Carcinoma Breast

An Uncommon Substype with Good Prognosis

  • Swati Sahay SNMC , Bagalkot, Karnataka , India
  • Aarushi Bansal SNMC , Bagalkot, Karnataka , India
  • Aditya Singh SNMC , Bagalkot, Karnataka , India
Keywords: Medullary carcinoma breast, BIRADS II, triple negative IHC markers

Abstract

Medullary carcinoma of the breast is an uncommon variant of invasive ductal carcinoma, which constitutes nearly 5% of all breast cancers in men and women. These tumours are often associated with favourable prognosis despite showing aggressive behaviour. In this study a patient presented with history of breast lump aged 48 years in left breast since one year .In mammography it was described as   BIRADS II and fine needle aspiration cytology showed suspicious for malignancy .Histopathology report showed medullary carcinoma breast lesion. Immunochemistry was also done for ER , PR and Her-2neu  and it showed negative for ER ,PR and HER 2 Neu.  

Author Biographies

Swati Sahay, SNMC , Bagalkot, Karnataka , India
Dept of Pathology
Aarushi Bansal, SNMC , Bagalkot, Karnataka , India
Dept of Pathology
Aditya Singh, SNMC , Bagalkot, Karnataka , India
Dept of Pathology

References

1. J. Huober, S. Gilber , A Goldrich , A ,S Coates , G Viale , K.N Price , M.M Regan , Prognosis of medullar breast cancer . Analysis of 13 international breast cancer study group trials . Annals of Oncology 2012, 23 pg 2843-2851 .
2. Jagtap . S , Saini .N , Jagtap .S , Saini. S . Medullary carcinoma of breast , Case report . International J of health care and biomedical research , Volume 03 , issue 04 , 2015 , pg 55-58
3 N. Sajjan , V. BR , M. Srinivasa . Cytomorphological study of medullary carcinoma breast in comparison to infiltration Ductal carcinoma . Journal of cytology , 2018 , 35, 195-98
4. Tavasolli FA, Devilee P. World health organization classification of tumours, Pathology and genetics of tumours of breast and female genital organs. Lyon: IARC press; 2003.
5. . Saad RS, Silverman JF. Breast. In: Bibbo M, editor. Comprehensive Cytopathology. 2nd ed. Elsiever; 1997. p. 713‑72.
6. Gattuso P, Reddy V, David O, Spitz D, Haber M. Infiltrating carcinoma: Pathological types. In Differential Diagnosis in Surgical Pathology. 2nd ed.US Saunders, Elsevier ; 2010. p. 170-214.
7. Howat A, Coghill S. Malignant breast tumours. In: Winifred G, editor. Diagnostic cytopathology, 3rd ed. US Elsevier US;Churchill Livingstone; 2010. p. 279-302.
8. Marginean F, Rakha AE, Ho BC, Ellis IO, Lee AH. Histological features of medullary carcinoma and prognosis in triple negative basal like carcinomas of the breast. Modern Pathology 2010;23:1357‑63.
9. Kuroda H, Tamaru J, Sakamoto G, Ohnisi K, Itoyama S. Immunophenotype of lymphocytic infiltration in medullary carcinoma of the breast. Virchows Arch 2005;446:10‑4.
10. Ridolfi RL, Rosen PP, Port A, Kinne D, Mike V. Medullary carcinoma of the breast: A clinicopathological study with 10 year follow‑up. Cancer 1977;40:1365‑85.
11. Santosh T, Bal AK, Patro MK, Choudhaury A. Medullary Breast Carcinoma: A Case Report and Review of Literature. J Cancer Science There 2015;7: 142‑145.
Published
2019-10-01
Section
Case Report